Leishmania parasite plasma membrane phospholipids

Leishmania parasite plasma membrane phospholipids are essential structural and functional components that maintain the integrity and fluidity of the protozoan cell surface, which is crucial for surviving the acidic environment of the host macrophage phagolysosome (Zhang & Beverley, 2010, Nature Reviews Microbiology). These phospholipids, including phosphatidylcholine and phosphatidylethanolamine, are involved in critical signaling pathways and the regulation of membrane-bound enzymes necessary for parasite virulence (Azzouz et al., 2005, Molecular and Biochemical Parasitology). They serve as the primary target for alkylphosphocholine drugs such as miltefosine, which is an analog of phosphatidylcholine that interferes with lipid metabolism and triggers apoptosis-like cell death (Dorlo et al., 2012, Journal of Antimicrobial Chemotherapy). The unique lipid composition of the Leishmania membrane, which differs significantly from mammalian cells in its specific lipid species and ratios, provides a basis for selective therapeutic intervention (Teixeira et al., 2016, Frontiers in Microbiology). Disruption of these phospholipids leads to increased membrane permeability, loss of electrochemical gradients, and eventual parasite lysis (Rakotomanga et al., 2007, Antimicrobial Agents and Chemotherapy). Consequently, these lipids and their biosynthetic pathways are central to the mechanism of action of several current and experimental anti-leishmanial agents.

Other names

Leishmanial membrane lipidsLeishmania surface phospholipidsParasite plasma membrane phospholipidsLeishmania membrane phospholipids

Inhibition of phospholipid biosynthesis (specifically phosphatidylcholine), disruption of membrane architecture and fluidity, and induction of apoptosis-like cell death.